2/11 This is how our journey evolved. The idea for this manuscript was based on our original discovery of a "SAg-like motif" and "neurotoxin-like" motifs in SARS-CoV-2 Spike.
BioRxiv (May 2020) biorxiv.org/content/10.110…
3/11 This research was then published in PNAS (September 2020) where we showed the potential role of this "SAg-like motif" not only in MIS-C, but also in adults patients with severe COVID. pnas.org/doi/full/10.10…
4/11 We further discussed the hypothesis that the “SAg-like motif” in SARS-CoV-2 may play a crucial role not only in MIS-C but also in severe COVID-19 in our “Paradigms and Perspectives” published in JACI (October 2020), sciencedirect.com/science/articl…
5/11 This hypothesis and our original findings were the basis of an article published in National Geographic October 2020. You can read it here: nationalgeographic.com/science/articl…
6/11 In Nov 2020, we deposited in bioRxiv our 1st report showing TCR repertoire skewing in MIS-C patients & expansion of TRBV11-2 T cells, which we predicted by computational studies to interact with the SARS-CoV-2 “SAg-like motif”. biorxiv.org/content/10.110…
7/11 Which was then published in JCI, and we also showed HLA class I–associated expansion of TRBV11-2 T cells in MIS-C patients. jci.org/articles/view/…
8/11 Using proteomics, RNA-sequencing, autoantibody arrays and B cell receptor sequencing, we then identified strong autoimmune signatures and pathogenic pathways associated with MIS-C. This work was published in JCI. jci.org/articles/view/…
9/11 We next showed that an anti-SEB monoclonal antibody can potentially bind the “SAg-like motif" and block SARS-CoV-2 cellular infection in vitro.
in BioRxiv (Nov 2020) and published in Structure in 2021 sciencedirect.com/science/articl…
10/11 all this work was highlighted and discussed by @rkhamsi in an article at "The Atlantic". You can read it on this link: theatlantic.com/science/archiv…
11/11 Finally, recent scientific advances on Long COVID led us to hypothesize that repeated exposure to the "SAg-like motif" may lead to autoimmunity & neurotoxins may lead to the neurological findings in PACS. These are the 2 key concepts of our new Frontiers immunology paper.
• • •
Missing some Tweet in this thread? You can try to
force a refresh